Use of cryodepleted plasma

Indications

Cryodepleted plasma is used as an alternative to fresh frozen plasma (FFP) for plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).

 

Modifications

None.  

 

Dosage

Volume depends on local plasma exchange protocols and the patient’s weight with a 10–15 mL/kg dose recommended.

Cryodepleted plasma should be ABO compatible with the recipient's red cells.

 

Updated May 2025

Related resources

Blood Component Information: An Extension of Blood Component Labels thumbnail

Blood Component Information: An Extension of Blood Component Labels

Guide
Information Sheet
Download pdf, 6MB

Further information

Related topics

Component compatibility

Cryodepleted plasma